Critical Appraisal

Nama mahasiwa :
NIM :
Kelompok :
Judul artikel :

Are the results of the trial valid?

(screening question)
Can’t tell
1. Did the trial address a Yes ( √) ( ) No ()
clearly focused issue?
An issue can be
focused in term of a. The eligibility
criteria were male
patients whowill have
uroflowmetry
examination with
ages above 50 years
and body mass index
(BMI) 18.5–
24.9 kg/m.
b. The patients
were asked to
measure bladder
volume and
a. The urinate, and then the
population examiner checked
studied the residual urine
b. The intervention
given c.Can’t tell
c. The comparator
given
Can’t tell
2. Was the assignment of Yes (√) ( ) No ( )
patients to treatments Patients who have
met the inclusion
criteria were
mL randomly divided
into three groups. The
first
group was given
water about 300 ml
(group A),
the second group was
given water about
400
mL (group B), and the
third group was given
water about 500 ml
(group C). For the
allocation
of participants, a
block randomization
by a
computer-generated
 list of random
number was
used by researchers
with no clinical
involvement
in the trial.
randomized?
Can’t tell
Yes ( √) ( ) No ( )

a. Each patients was

given a sealed-bottle,
and description
amount of water
given was
contained in a sealed
envelope. All sealed-
bottles
have same
dimension, color, and
appearance. The
period of drinking
was ten minutes. The
patients
did not allow drink
or urinate until they
felt
first sensation of
micturition. The staff
member
noted time and
bladder volume
when the subject
wanted to urinate for
the first time at the
same
day with
randomization.
Bladder volume was
assessed by
ultrasonography. The
staff member
who obtained
outcome
measurement was
not
informed of the
group assignment.
The staff
who delivered the
3. Were all of the patients intervention did not
who entered the trial take the
properly accounted for outcome
at its conclusion? measurements.
a. Was follow up
 b. Water intake is
defined by volume of
water which
was given by
researchers to be
taken by patients.
The volume of water
intake has been
determined
to 300 ml, 400 ml,
and 500 ml. Waiting
time is
defined by the time
from ingestion of
water until
first sensation of
micturition. The time
is noted in
b. complete? minutes.
Were patients
analysed in the
groups to which
they were
randomised?
Detailed Question
Can’t tell
Yes ( √) ( ) No ( )

This trial was

designed as a
randomized,
4. Were patients, health researchers,
workers and study caregivers and
personel “blind” to patients blinded,
treatment?
c. Were the patients
d. Were the health
workers
e. Were the study
personel.
Can’t tell
5. Were the groups similar Yes ( √) ( ) No ( )
at the start of the trial?

19
 Penuntun Praktikum Blok 4.3 Ilmu Kesehatan Masyarakat T. A 2017/2018

The eligibility
criteria were
male patients
with ages above
50 years and
body mass index
18.5–24.9 kg/m
In term of other factors
that might effect the
outcome such as age,
sex, social class.
6. Aside from the Yes ( √) Can’t tell ( ) No ( )
experimental
intervention, were the
groups treated equally?
What are the
results?
7. How large was the Yes ( √) Can’t tell ( ) No ( )
This study is the
first study that
investigated
relationship
between the water
intake and the
waiting time prior
to uroflowmetry.
The result
of this study
indicated that
waiting time before
uroflowmetry
study reduced as
the volume of
water intake
increased (300,
400, and 500 ml).
treatment effect? What
outcomes are
measured?
8. How precise was the Yes ( √) Can’t tell ( ) No ( )
estimate of the
treatment effect? However, this
relationship was
not significant
(p=0.07). P<0.05
was considered
statistically
 significant
What are its confidence
limits?
Will the results help locally?
9. Can the results be Yes ( √) Can’t tell ( ) No ( )
applied to the local
population?
Do you think that the
patients covered by the
trial are similar enough
to your population?
10. Were all clinically Yes ( √) Can’t tell ( ) No ( )
important outcomes
considered?
If not, does this affect
the decision?
11. Are the benefits worth Yes ( √) Can’t tell ( ) No ( )
the harms and costs?
This is unlikely to be
addressed by the trial.
But what do you think?

Nilai akhir (0-100) :

Nama Mahasiswa Nama instruktur

( ) ( )
NIM. NIP.

harvina.sawitri@unimal.ac.id